1. Home
  2. MNPR vs GROY Comparison

MNPR vs GROY Comparison

Compare MNPR & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

N/A

Current Price

$70.28

Market Cap

587.4M

Sector

Health Care

ML Signal

N/A

Logo Gold Royalty Corp.

GROY

Gold Royalty Corp.

N/A

Current Price

$2.55

Market Cap

702.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MNPR
GROY
Founded
2014
2020
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
587.4M
702.0M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
MNPR
GROY
Price
$70.28
$2.55
Analyst Decision
Strong Buy
Buy
Analyst Count
12
8
Target Price
★ $130.17
$5.03
AVG Volume (30 Days)
127.0K
★ 1.6M
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 54.99
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$121.78
Revenue Next Year
N/A
$32.35
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$50.07
$2.45
52 Week High
$124.82
$5.45

Technical Indicators

Market Signals
Indicator
MNPR
GROY
Relative Strength Index (RSI) 42.77 36.09
Support Level $66.88 N/A
Resistance Level $75.33 $2.72
Average True Range (ATR) 4.74 0.14
MACD 0.73 -0.03
Stochastic Oscillator 51.81 0.57

Price Performance

Historical Comparison
MNPR
GROY

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.

About GROY Gold Royalty Corp.

Gold Royalty Corp is principally engaged in acquiring gold-focused royalties, streaming, and similar interests. It is a gold-focused royalty company offering creative financing solutions to the metals and mining industry. The Company operates in Bosnia and Herzegovina, Canada, which generates maximum revenue, the USA, Brazil, and Mexico.

Share on Social Networks: